hyperpigmentation disorders treatment Analysis
Hyperpigmentation disorder are harmless skin condition caused by darkened skin patches. Rising demand for outpatient dermabrasion procedures, increasing adoption of lasers and growing cosmetics expenditure are expected to drive the growth of the market. Additionally, rising R&D spending followed aggressive strategies by the key market players is generating awareness for the disease boosting the market to grow.
The global hyperpigmentation disorders treatment Market was anticipated to held a market value of USD 3,915 million in the year 2017 and is expected to grow at a CAGR of 7.1% during the forecast period.
Segmentation of The global hyperpigmentation disorders treatment market Segments has been segmented based on treatment type, disease indication, end-user, and region.
Based on treatment type, the market has been classified as topical drugs, chemical peels, microdermabrasion, laser therapy, phototherapy, and others. The market, by disease indication, has been segmented into melasma, solar lentigines, post-inflammatory hyperpigmentation, and others. based on end-user, the market has been segmented into hospitals, aesthetic clinics & dermatology centers, and others. The topical drugs segment is expected to hold the largest market share of the hyperpigmentation disorders treatment market, by treatment type, during the forecast period. Also, by disease indication melasma segment register the considerable growth in comparison to other disease indication.
hyperpigmentation disorders treatment Market Key Players:
Some of the key players in the global hyperpigmentation disorders treatment market Allergan, Inc., Bayer AG, EpiPharm AG, Episciences, Inc., Galderma laboratories (Nestle Skin Health S.A), Obagi Cosmeceuticals LLC, Pierre Fabre, RXi Pharmaceuticals Corporation, SkinCeuticals International, and Vivier Pharma.
Browse Complete Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/hyperpigmentation-disorders-treatment-market-7462
hyperpigmentation disorders treatment Market Regional Analysis
The Asia-Pacific are likely to dominate the global hyperpigmentation disorders treatment market. Rising awareness of hyperpigmentation disorders, presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure are some of the factors driving the market.
The Americas stood second in the global hyperpigmentation disorders treatment market owing to government funding and support for healthcare sector. Moreover, presence of developed economies like US and Canada provides suitable backgrounds for the market growth.
Europe is expected to be the third largest hyperpigmentation disorders treatment market Size . Following the Europe, the Middle East & Africa is expected to account for the least share of the global hyperpigmentation disorders treatment market.
Comments
Post a Comment